Safety Considerations When Initiating Treatment for PBC
Panelists discuss how safety considerations for primary biliary cholangitis (PBC) treatment include monitoring liver function tests, managing pruritus and fatigue, assessing drug interactions, and evaluating individual patient factors like pregnancy status and comorbidities, which all influence the choice between ursodeoxycholic acid and second-line therapies.
Video content above is prompted by the following:
What are the primary safety considerations when initiating treatment for primary biliary cholangitis, and how do these considerations influence initial therapy selection?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Encouraging Successful Completion of the Shingles Vaccine Series
September 16th 2025
- A Pharmacist’s View of Emerging CML Treatment
September 4th 2025
- Potential for Precision: Exploring Targeted Therapies in mCRC Care
September 4th 2025
- Empowering Pharmacists in the Management of Patients With Urothelial Cancer
September 3rd 2025
- Empowering Pharmacists in the Management of Patients With Urothelial Cancer
September 1st 2025